Healthcare Sales & Marketing Network News: intranasal ketamine

Searching News Database: intranasal ketamine

HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 10 Aug 2015
Turing Pharmaceuticals Announces $90 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Aug 2009
Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain
Biopharmaceuticals Drug Delivery Surgery

HSMN NewsFeed - 19 Dec 2007
Javelin Pharmaceuticals Announces Peer-Reviewed Publication of Successful Postoperative Pain Trial with PMI-100/150 (Intranasal Ketamine) in International Journal, ''Acute Pain''
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 14 Dec 2007
Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day
Biopharmaceuticals

HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2007
Javelin Pharmaceuticals Announces Results of FDA Meeting for Nasal Ketamine
Biopharmaceuticals Drug Delivery FDA

Return to NewsFeed

Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 2 additional stories matching:
intranasal ketamine
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.